Oribe shampoo recalled in US and Canada over bacteria risk
DIRECT ANSWER: Kao USA issued a voluntary pluralibacter gergoviae shampoo recall for select Oribe Serene Scalp Densifying Shampoo lots in the U.S. and Canada. The FDA announced the action after bacteria were found in bottles made February 21–26, 2026. Healthy adults face little risk, but stop use if your lot matches.
Key Takeaways
- Only specific lots of Oribe Serene Scalp Densifying Shampoo are affected—not the entire product line.
- Lot codes YR010556, YR010566, and YR010576 are printed in black on the bottom of recalled bottles.
- Pluralibacter gergoviae poses little risk to healthy people but may threaten those with weakened immune systems.
- Kao USA is working with the FDA to pull affected inventory from warehouses, salons, and retailers.
- Consumers can request a replacement by calling 800-333-2442 or emailing oribecomplaints@kao.com.
If you use salon-grade scalp treatments as part of a longevity or wellness routine, a contaminated bottle is a product-safety issue worth a two-minute label check—not a reason to panic. Kao USA, parent company of the luxury hair-care brand Oribe, voluntarily recalled the shampoo after routine testing flagged bacterial contamination in a limited batch.
The U.S. Food and Drug Administration publicized the recall, which covers products distributed in the U.S. and Canada. Kao said it is still investigating how widespread the problem may be while coordinating with regulators to remove affected units from the supply chain.
Which Oribe shampoo lots are affected by the recall?
The recall is limited to Oribe Serene Scalp Densifying Shampoo in two sizes. Check the lot code printed in black on the bottom of your bottle against the list below.
8.5-oz bottle (UPC 840035231242): lot code YR010556.
33.8-oz bottle (UPC 840035231273): lot codes YR010566 or YR010576.
All recalled units were manufactured between February 21 and February 26, 2026. Other Oribe products and other lots of this shampoo are not part of the notice, according to USA Today.
How risky is Pluralibacter gergoviae for healthy users?
Kao USA and the FDA say Pluralibacter gergoviae poses little medical risk to healthy people. The environmental bacterium can contaminate cosmetics and is partly resistant to parabens and other preservatives used to keep products shelf-stable—a factor cited in a major 2024 Amika shampoo recall for the same organism.
People with weakened immune systems, chronic illnesses, or those recovering from surgery may face a higher infection risk. Cosmetics Business reports the bacterium has been linked to respiratory illness, urinary tract infections, eye infections, and sepsis in vulnerable patients. Kao is urging all consumers with affected bottles to discontinue use regardless of health status.
What should you do if your shampoo is recalled?
Stop using any bottle that matches the lot codes above. Do not try to salvage the product by diluting or filtering it. Salons and retailers are being asked to pull affected stock from sale and return it to Kao for safe disposal.
To arrange a replacement, report an adverse event, or ask questions, contact the Kao Professional Hair Technical Hotline at 800-333-2442 or email oribecomplaints@kao.com. If you believe you experienced a health problem after using the shampoo, contact your healthcare provider and report the incident to Kao through the same channels.
Why does this recall matter for scalp-care shoppers?
Scalp-focused shampoos marketed for thinning hair sit at the intersection of beauty and personal health—a space our Longevity & Biohacking coverage watches closely. A voluntary recall on a premium brand is a reminder that even high-end personal-care products can fail quality controls.
For biohackers and wellness-minded consumers who invest in targeted scalp treatments, the practical takeaway is simple: verify lot codes on products already in your shower, and treat FDA-announced cosmetic recalls with the same attention you would give a supplement or device safety alert.